Human Bcl-9 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3996
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human Bcl-9
Met1009-Gly1328
Accession # O00512
Met1009-Gly1328
Accession # O00512
Specificity
Detects endogenous human Bcl-9 in Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Human Bcl-9 Antibody
Detection of Human Bcl-9 by Western Blot.
Western blot shows lysates of HCT-116 human colorectal carcinoma cell line and K562 human chronic myelogenous leukemia cell line. PVDF membrane was probed with 1 µg/mL of Human Bcl-9 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3996) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for Bcl-9 at approximately 150 kDa (as indicated). This experiment was conducted using Immunoblot Buffer Group 1.Applications for Human Bcl-9 Antibody
Application
Recommended Usage
Western Blot
1 µg/mL
Sample: HCT-116 human colorectal carcinoma cell line and K562 human chronic myelogenous leukemia cell line
Sample: HCT-116 human colorectal carcinoma cell line and K562 human chronic myelogenous leukemia cell line
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Bcl-9
Bcl-9 (B-cell lymphoma 9; also Protein legless homolog) is a transcriptional regulator that belongs to the Bcl-9 family of proteins. It is expressed in multiple tissues and serves to recruit Pygopus to the Wnt-pathway beta-catenin-TCF complex in the nucleus. Bcl-9 and Bcl-9-2 are considered evolutionary duplicates of Legless that perform the same task with different regulation. Human Bcl-9 is 1426 amino acids (aa) in length. It contains one phosphothreonine and three phosphoserine sites that have been identified so far, two poly-Pro regions (aa 514‑517 and 970‑973), and one poly-Ala segment (aa 900‑903). There is one potential alternate start site at Met27, and a variant isoform exists that shows a four aa substitution for aa 1391‑1426. Over aa 1009‑1328, human Bcl-9 is 96% aa identical to mouse Bcl-9.
Long Name
B Cell Lymphoma/Leukemia 9, Nuclear Co-factor of beta-Catenin Signaling
Alternate Names
Bcl9, BCL9L, LGS
Gene Symbol
BCL9
UniProt
Additional Bcl-9 Products
Product Documents for Human Bcl-9 Antibody
Product Specific Notices for Human Bcl-9 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...